All terms in EFO
| Label | Id | Description |
|---|---|---|
| menstrual cycle measurement | EFO_0007786 | [quantification of some aspect's of a female's menstrual cycle such as its length] |
| RNAlater specimen | EFO_0005125 | [a specimen which has been treated with RNAlater, with the aim of preserving specimen RNA prior to extraction] |
| femoral neck bone mineral density | EFO_0007785 | [mineral density of the neck of the femur, the region just below the ball of the hip joint] |
| functional decline measurement | EFO_0007784 | [quantification of some aspect of muscle function deterioration such as the rate at which it occurs or its severity, for example in patients with neurodegenerative conditions such as ALS. Functional decline is ususally assessed using a combination of physical exams and structured-interview protocols covering a number of standardised areas.] |
| albumin:globulin ratio measurement | EFO_0005128 | [quantification of the ratio of the protein albumin to globulin in the blood serum] |
| serum albumin | PR_000003918 | [A protein that is a translation product of the human ALB gene or a 1:1 ortholog thereof. Serum albumin is produced by the liver, occurs dissolved in blood plasma and is the most abundant blood protein in mammals.] |
| sorting nexin-4 measurement | EFO_0020747 | [The determination of the amount of sorting nexin-4 in a sample] |
| hepatitis C induced liver cirrhosis | EFO_0005129 | [liver injury resulting from hepatitis C infection, Liver injury resulting from hepatitis C infection.] |
| hepatitis C virus infection | EFO_0003047 | [A Hepacivirus infectious disease which is a chronic bloodborne infectious disease caused by Hepatitis C virus. The symptoms include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, clay-colored bowel movements, joint pain and jaundice., A viral infection caused by the hepatitis C virus., A viral hepatitis and is_a Hepacivirus infectious disease, that results_in inflammation located_in liver, has_agent Hepatitis C virus, which is transmitted_by blood from an infected person enters the body of an uninfected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice., A Hepacivirus infectious disease and is_a viral hepatitis that results_in inflammation located_in liver, has_agent Hepatitis C virus, which is transmitted_by blood from an infected person enters the body of an uninfected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.] |
| SPARC measurement | EFO_0020748 | [The determination of the amount of SPARC in a sample] |
| Aplasia cutis - myopia | Orphanet_1117 | |
| BMI-adjusted waist circumference | EFO_0007789 | [waist circumference measurement that has been adjusted by subjects’ body mass index] |
| waist circumference | EFO_0004342 | [The measurement around the body at the level of the ABDOMEN and just above the hip bone. The measurement is usually taken immediately after exhalation.] |
| arylesterase enzyme measurement | EFO_0005126 | [quantification of the activity of enzymes from the arylesterase family. Low measurements have been associated with cardiovascular risk - http://europepmc.org/abstract/MED/22982463] |
| spectrin alpha chain, non-erythrocytic 1 measurement | EFO_0020749 | [The determination of the amount of spectrin alpha chain, non-erythrocytic 1 in a sample] |
| Fibular aplasia - ectrodactyly | Orphanet_1118 | |
| Dysostosis with combined reduction defects of upper and lower limbs | Orphanet_294957 | |
| BMI-adjusted waist-hip ratio | EFO_0007788 | [waist-hip ratio that has been adjusted by subjects’ body mass index] |
| waist-hip ratio | EFO_0004343 | [The waist circumference measurement divided by the hip circumference measurement. For both men and women, a waist-to-hip ratio (WHR) of 1.0 or higher is considered "at risk" for undesirable health consequences, such as heart disease and ailments associated with OVERWEIGHT. A healthy WHR is 0.90 or less for men, and 0.80 or less for women. (National Center for Chronic Disease Prevention and Health Promotion, 2004)] |
| obsolete_recessive aplasia cutis congenita of limbs | Orphanet_1115 |